Designed to meet the demands of translational research, our preclinical grade cytokines are ideal to allow for a seamless transition from preclinical development to the clinical stage. CellGenix^® preclinical and GMP cytokines are produced under the same conditions in a GMP facility, using identical production steps and expression systems. This ensures an equal product quality and performance.​

The difference between both quality levels is that we offer a more comprehensive QC testing including tighter specifications and documentation for our GMP products. Our preclinical grade products, therefore, offer a cost-efficient alternative for the early development phase when regulatory support and quality of raw materials have a lower priority and access to GMP-relevant documentation is not required yet.